eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer

Lucy Batizovsky | March 6, 2026 | Appointment | |  eXmoor Pharma 

eXmoor Pharma has appointed Manuel Balbuena as Chief Commercial Officer (CCO).

Manuel brings more than 15 years of commercial leadership experience to the role, including seven years in the cell and gene therapy and biologics CDMO industry. Previously, he held senior commercial roles across Europe at AGC Biologics.

Lucy Foley, CEO of eXmoor Pharma, said: “Manuel’s deep experience within the cell and gene therapy and biologics CDMO sector strengthens our ability to partner with global clients across a range of complex modalities.”

Advertisement

As CCO, Manuel will lead the company’s global commercial strategy, strengthen existing client relationships, build new strategic partnerships and support the company’s expansion across Europe, the US and other international markets.

His appointment reflects eXmoor’s continued evolution as an integrated consultancy and GMP manufacturing partner supporting innovators across viral vectors, cell therapies and RNA technologies.

Manuel said: “Having worked across global CDMO organisations, I recognise the importance of aligning technical depth with commercial clarity. eXmoor’s integrated model creates a strong platform for sustainable growth.

“I look forward to strengthening our partnerships with existing clients, developing new strategic relationships and supporting advanced therapy innovators as they translate complex science into clinical and commercial reality.”
 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content